Pharma Focus Asia

HitGen and Morphic Extend Drug Discovery Research Collaboration

Monday, July 06, 2020

HitGen Inc announced that HitGen and Morphic Therapeutic have extended their drug discovery research collaboration to identify small molecule leads against targets specified by Morphic. HitGen’s industry-leading DNA-encoded library (DEL) technology platform includes over 400 billion encoded syntheses of small molecules with drug-like properties, synthesized on chemically-diverse scaffolds. The collaboration is an extension of a previous agreement which identified active lead compounds that were exclusively licensed to Morphic.

Under the terms of the extended agreement, HitGen will use its platform technology, based on the design, synthesis and interrogation by selection of DELs to discover ligands for targets of interest to Morphic. Morphic will pay an assignment fee to HitGen in exchange for exclusive development and commercialization rights to compounds that achieve the criteria of the collaboration.

“The HitGen DEL platform provides chemical libraries that are excellent starting points for Morphic to expand the diversity of our compound collection targeting integrin receptors,” commented Bruce Rogers, PhD, Chief Scientific Officer at Morphic Therapeutic Inc. “We are enthusiastic to expand this collaboration and build upon our previous work together.”

“We are delighted to announce the extension of our collaboration with Morphic Therapeutic. The delivery of compounds under our initial agreement demonstrates the ability of our DEL platform to discover novel small molecule ligands against a variety of technically challenging targets. We look forward to further success in identifying small molecule compounds in our continued collaboration with Morphic,” noted Dr. Jin Li, Chairman of the Board and Chief Executive Officer of HitGen.

magazine-slider-imageMFA + MMA 2024CPHI Chine || PMEC China 2024Asia Healthcare Week 2024Advance DoE WorkshopNitrosamine Advance Workshop 2024CPHI Korea 2024CHEMICAL INDONESIA 2024INALAB 2024 Thermo Scientific - DynaDrive and DynaSpinDigital Health Asia 2024Rehab Expo 2024ISPE Singapore Affiliate Conference & Exhibition 20242024 PDA Pharmaceutical Manufacturing & Quality Conference2024 PDA Cell and Gene Pharmaceutical Products Conference 2024 PDA Aseptic Manufacturing Excellence Conference2024 PDA Aseptic Processing of Biopharmaceuticals ConferencePharma Quality Excellence Awards 20244th Annual Pharma GMP Quality Management 20243rd World ADC Asia 2024LogiPharma Asia 2024